January 15, 2018

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Pre-Registration is Now Closed. Please Register Onsite at the Meeting
We hope you can join us for the NRG Oncology Semiannual Meeting, January 25-27, 2018 at the Phoenix Convention Center in Phoenix, AZ. Meeting information is available on the NRG Oncology website.

Last chance to register for the training session for NRG-HN004 Lead-in webinar!
NRG Oncology will be holding a training session for NRG-HN004: Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin on Friday, January 26, 2018 from 10-11 am Mountain Standard Time. The training session will be held at the NRG Oncology Semiannual Meeting at the Phoenix Convention Center and is open to all attendees. If you are unable to attend the event in-person, REGISTER TODAY to participate in the live webinar of the training session. Please contact Erin Cunningham at cunninghame@nrgoncology.org with any questions.

CTN/CRA Educational ProgramsREMINDER!
Slide sets for the CTN/CRA Program, Introduction to Clinical Trials: Principles of Clinical Trial Management, on Thursday, January 25, 2018, and for the Educational Session for Clinical Trial Nurses and Clinical Research Associates, on Friday, January 26, 2018, are posted to Nurses and CRA /Education and Training on the NRG Oncology website. (A password is required.) If you plan to attend these sessions, please download the slides prior to the meeting and bring them with you. No handouts will be provided at the meeting. Also, please check the NRG Oncology website frequently prior to the meeting, as additional presentations may be added.

CCD 800-line Coverage during the Meeting
Information regarding the availability of the NRG Oncology-Pittsburgh Center Clinical Coordinating Department (CCD) during the NRG Oncology meeting is posted to the NRG Oncology Meeting Information page and the CTSU website.

Social Media at NRG Oncology Semiannual Meeting
Using Twitter? Follow us @NRGOnc and use our meeting hashtag #NRG18. We also have a Facebook page. ‘Like’ NRG Oncology to follow our latest news.

RTOG 0920: Amendment 11, version date November 13, 2017. Documents are available on the CTSU website

NRG-BR003: Information/Summary sheet (posted to CTSU).

NRG-BR005: E-mail Blast (posted to CTSU).

NSABP B-55/BIG 6-13: OlympiA Newsletter, 17th Issue (posted to CTSU).

NSABP B-55/BIG 6-13: Statistical/Progress Report (posted to NRG Oncology).

NRG-GI002: IMPORTANT NOTICE! NRG Oncology is closely monitoring accrual to his rapidly enrollingtrial. (Information posted to CTSU).

NRG-GI002: E-mail Blast, FAQ memorandum, and FAQ document (posted to CTSU).

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat. The next training will be held at the NRG Oncology Semiannual meeting on January 25 at 1 pm. Please see the NRG meeting agenda for details.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP E-mail Distributions page and the CTSU website.

An IB update has been issued for the following NRG Oncology studies:
Cedarinib: NRG-GY004, NRG-GY005

The current version of the Investigator Brochure Documents (Investigator Brochure, Summary of Changes) for Cediranib (AZD2171) NSC 732208 for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials is available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website ( https://eapps-ctep.nci.nih.gov/OAOP/pages/login.jspx). Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

Martin Luther King Day closure information
A reminder that the following NRG Oncology locations will be closed in observance of Martin Luther King Day today, Monday, January 15, 2018. All other locations will be open during regular business hours.
- Philadelphia East Operations Center
- Philadelphia West Operations Center
- Buffalo SDMC
- Philadelphia SDMC
- Pittsburgh SDMC
- Biospecimen Bank – San Francisco (no shipping restrictions)
- Serum Bank – Baylor (no shipping restrictions)

Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings
American Society of Clinical Oncology (ASCO) GI; Jan 18-20, 2018; San Francisco, CA

Upcoming Abstract Submission Deadlines
American Association for Cancer Research (AACR); Apr 14-18, 2018; Chicago, IL; due to publications committee Jan 16, 2018; Clinical Trials abstract placeholder submission deadline Tuesday Jan 23, 2018; Final data for placeholder abstracts due Feb 23, 2018; Late-Breaking abstract submission deadline Tuesday Jan 23, 2018

American Society of Clinical Oncology (ASCO); Jun 1-5, 2018; Chicago, IL; due to publications committee Jan 23, 2018; meeting abstracts submission deadline Feb 13, 2018; Late-breaking Mar 15, 2018

American Society for Radiation Oncology (ASTRO); Oct 21-24, 2018; San Diego, CA; due to publications committee Jan 30, 2017; meeting abstracts submission deadline Feb, 142018; Late-breaking Aug 1, 2018

Multinational Association of Supportive Care in Cancer (MASCC); Jun 28-30, 2018; Vienna, Austria; due to publications committee Jan 26, 2018; meeting abstracts submission deadline Feb 9, 2018; Late-breaking due Apr 22, 2018

Society of Gynecologic Oncology (SGO); Mar 24-27, 2018; New Orleans, LA; Late-breaking deadline: Jan 17, 2018

NRG Oncology is proud to be an active participant of #CancerMoonShot.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address